NZ228427A - Dna sequence encoding a polypeptide having similar activity to epidermal growth factor (egf) - Google Patents

Dna sequence encoding a polypeptide having similar activity to epidermal growth factor (egf)

Info

Publication number
NZ228427A
NZ228427A NZ228427A NZ22842789A NZ228427A NZ 228427 A NZ228427 A NZ 228427A NZ 228427 A NZ228427 A NZ 228427A NZ 22842789 A NZ22842789 A NZ 22842789A NZ 228427 A NZ228427 A NZ 228427A
Authority
NZ
New Zealand
Prior art keywords
egf
polypeptide
growth factor
sequence encoding
dna sequence
Prior art date
Application number
NZ228427A
Other languages
English (en)
Inventor
Joseph P Brown
Shiu-Lok Hu
Hans Marquardt
Daniel R Twardzik
George J Todaro
A Gregory Bruce
Timothy M Rose
Antonio F Purchio
Suo Win Liu
Thomas J Franceschini
Mohammed Shoyab
Gregory D Plowman
Wen Chang
Original Assignee
Oncogen
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oncogen filed Critical Oncogen
Publication of NZ228427A publication Critical patent/NZ228427A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/485—Epidermal growth factor [EGF], i.e. urogastrone
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/495—Transforming growth factor [TGF]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62—DNA sequences coding for fusion proteins
    • C12N15/625—DNA sequences coding for fusion proteins containing a sequence coding for a signal sequence
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
    • C07K2319/74—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor
    • C07K2319/75—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor containing a fusion for activation of a cell surface receptor, e.g. thrombopoeitin, NPY and other peptide hormones
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/24011—Poxviridae
    • C12N2710/24022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/24011—Poxviridae
    • C12N2710/24111—Orthopoxvirus, e.g. vaccinia virus, variola
    • C12N2710/24122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Wood Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Toxicology (AREA)
  • Plant Pathology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Urology & Nephrology (AREA)
  • Public Health (AREA)
  • Food Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • Dermatology (AREA)
  • Endocrinology (AREA)
NZ228427A 1988-03-24 1989-03-21 Dna sequence encoding a polypeptide having similar activity to epidermal growth factor (egf) NZ228427A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US17265388A 1988-03-24 1988-03-24

Publications (1)

Publication Number Publication Date
NZ228427A true NZ228427A (en) 1993-03-26

Family

ID=22628611

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ228427A NZ228427A (en) 1988-03-24 1989-03-21 Dna sequence encoding a polypeptide having similar activity to epidermal growth factor (egf)

Country Status (22)

Country Link
JP (1) JPH0279981A (OSRAM)
KR (1) KR890014743A (OSRAM)
AU (2) AU3169589A (OSRAM)
BE (1) BE1004202A5 (OSRAM)
CH (1) CH681081A5 (OSRAM)
DE (1) DE3910084A1 (OSRAM)
DK (1) DK146789A (OSRAM)
ES (1) ES2013408A6 (OSRAM)
FI (1) FI891308L (OSRAM)
FR (1) FR2632321A1 (OSRAM)
GB (1) GB2219799B (OSRAM)
GR (1) GR1000876B (OSRAM)
HU (1) HUT50501A (OSRAM)
IE (1) IE890950L (OSRAM)
IL (1) IL89673A0 (OSRAM)
IT (1) IT1234961B (OSRAM)
LU (1) LU87489A1 (OSRAM)
NL (1) NL8900724A (OSRAM)
NO (1) NO891273D0 (OSRAM)
NZ (1) NZ228427A (OSRAM)
PT (1) PT90118B (OSRAM)
SE (1) SE8901031L (OSRAM)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU626524B2 (en) * 1987-05-29 1992-08-06 Bristol-Myers Squibb Company Cloning and expression of simian transforming growth factor- beta 1
CA2037440A1 (en) * 1990-03-02 1991-09-03 Gregory D. Plowman Her3: a novel egf receptor homolog
EP0739984A1 (en) * 1995-04-26 1996-10-30 San Tumorforschungs-Gmbh Bivalent polypeptides containing at least two domains
AU5549296A (en) * 1996-04-10 1997-10-29 Human Genome Sciences, Inc. Extracellular/epidermal growth factor-like protein
US6852506B1 (en) 1996-04-10 2005-02-08 Human Genome Sciences, Inc. Extracellular/epidermal growth factor-like protein

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0108132A1 (en) * 1982-05-06 1984-05-16 Applied Molecular Genetics Inc. The manufacture and expression of genes for urogastrone and polypeptide analogs thereof
JPS6028994A (ja) * 1983-07-08 1985-02-14 Wakunaga Seiyaku Kk 〔２１―ロイシン〕ヒトウロガストロン
WO1985002198A1 (en) * 1983-11-01 1985-05-23 Amgen Microbial expression of type i transforming growth factor, polypeptide analogs thereof and hybrid egf/tgf polypeptides
JP2554459B2 (ja) * 1984-07-02 1996-11-13 アース製薬 株式会社 β−ウロガストロン遺伝子、対応プラスミド組換体及び対応形質転換体
JPS62501071A (ja) * 1984-10-30 1987-04-30 オンコゲン 成長因子活性を有する新規なポリペプチド及び該ポリペプチドをコ−ドする核酸配列
GB8507666D0 (en) * 1985-03-25 1985-05-01 Wellcome Found Epidermal growth factor production
US4743679A (en) * 1986-02-24 1988-05-10 Creative Biomolecules, Inc. Process for producing human epidermal growth factor and analogs thereof
GB2210618B (en) * 1987-10-08 1991-10-16 British Bio Technology Synthetic egf gene
EP0314184B1 (en) * 1987-10-30 1995-12-13 Bristol-Myers Squibb Company Expression plasmids
JP2970811B2 (ja) * 1987-10-30 1999-11-02 オンコゲン ア リミテッド パートナーシップ 原核生物細胞中にポリペプチドを調製するための発現システム

Also Published As

Publication number Publication date
GB2219799B (en) 1992-10-14
ES2013408A6 (es) 1990-05-01
FI891308A0 (fi) 1989-03-20
LU87489A1 (fr) 1989-10-26
PT90118B (pt) 1994-07-29
GR890100185A (en) 1990-01-19
JPH0279981A (ja) 1990-03-20
CH681081A5 (OSRAM) 1993-01-15
PT90118A (pt) 1989-11-10
NL8900724A (nl) 1989-10-16
FI891308A7 (fi) 1989-09-25
KR890014743A (ko) 1989-10-25
HUT50501A (en) 1990-02-28
AU2990492A (en) 1993-03-04
IT1234961B (it) 1992-06-09
NO891273D0 (no) 1989-03-22
DE3910084A1 (de) 1989-11-16
SE8901031D0 (sv) 1989-03-22
GB8906758D0 (en) 1989-05-10
GB2219799A (en) 1989-12-20
AU3169589A (en) 1989-09-28
DK146789A (da) 1989-09-25
IE890950L (en) 1989-09-24
DK146789D0 (da) 1989-03-22
SE8901031L (sv) 1989-09-25
IT8919917A0 (it) 1989-03-24
IL89673A0 (en) 1989-09-28
GR1000876B (el) 1993-03-16
FR2632321A1 (fr) 1989-12-08
FI891308L (fi) 1989-09-25
BE1004202A5 (fr) 1992-10-13

Similar Documents

Publication Publication Date Title
IL87025A (en) Recombinant human basic fibroblast growth factor analogs, their production, dna sequences encoding therefor and recombinant vectors and host cells containing said dna sequences
US5405776B1 (en) Cloned genes encoding reverse transcriptase lacking RNase H activity
GB8819209D0 (en) Polypeptide & dna encoding same
DK579787D0 (da) Stabiliserede praeparater indeholdende epidermal vaekstfaktor
GR862009B (en) Intermediates in polypeptide synthesis
GR862367B (en) Growth factors
IL85372A0 (en) Peptides with laminin-like activity
GB2172890B (en) Epidermal growth factor production
GB8823068D0 (en) Recombinant dna
EP0354641A3 (en) Recombinant dna encoding a 4''-0-isovaleryl acylase
IL82052A0 (en) Alpha interferon analogue and method for producing a protein having alpha interferon activity
IL89673A0 (en) Novel polypeptides having growth factor activity and nucleic acid sequences encoding the polypeptides
PH24603A (en) Novel polypeptides having growth factor activity and nucleic acid sequences encoding the polypeptides
GB2223496B (en) Synthetic gene encoding mature human acid fibroblast growth factor
GB2223495B (en) Synthetic gene encoding basic fibroblast growth factor
NZ230797A (en) Recombinant polypeptide having ovine growth hormone activity
GB2233655B (en) Dna coding for a polypeptide signal sequence in vaccinia virus
IE852704L (en) Novel polypeptides having growth factor activity and¹nucleic acid sequences encoding the polypeptides
GB2195641B (en) Polypeptide with interleukin-2 activity
GB2208482B (en) Dual-bed catalyst
IE882056L (en) Recombinant fibroblast growth factors
ZA908042B (en) Recombinant growth factors
IE883495L (en) Analogs of fibroblast growth factor
GB8603797D0 (en) Recombinant catalysts
NZ233946A (en) A recombinant dna molecule coding for a modified factor viii:c-like polypeptide